Preclinical evaluation of immunomodulatory effects of aurora kinase inhibition in HPV plus cancers

被引:1
|
作者
Sinha, Pragya
Ghosh, Soma
Johnson, Faye M.
Sastry, Jagannadha K.
机构
关键词
D O I
10.1158/1538-7445.AM2023-5021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5021
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Inhibition of Aurora A and Aurora B Is Required for the Sensitivity of HPV-Driven Cervical Cancers to Aurora Kinase Inhibitors
    Martin, David
    Fallaha, Sora
    Proctor, Martina
    Stevenson, Alexander
    Perrin, Lewis
    McMillan, Nigel
    Gabrielli, Brian
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (09) : 1934 - 1941
  • [2] Aurora kinase inhibitors cause cell death in HPV plus cells: A plausible treatment option for HPV plus cancers.
    Mazumdar, Tuhina
    Shen, Li
    Xu, Wei
    Ghosh, Soma
    Powell, Reid T.
    Stephan, Clifford
    Pickering, Curtis R.
    Myers, Jeffery N.
    Wang, Jing
    Johnson, Faye M.
    CANCER RESEARCH, 2021, 81 (13)
  • [3] TARGETING AURORA KINASE TO ENHANCE THE CURATIVE POTENTIAL OF RADIOTHERAPY IN HPV RELATED CANCERS
    Chaudary, Naz
    Idris, Adi
    McMillian, Nigel
    Hill, Richard
    Milosevic, Michael
    RADIOTHERAPY AND ONCOLOGY, 2019, 139 : S27 - S27
  • [4] Targeting Aurora Kinase to Enhance the Curative Potential of Radiotherapy in HPV Related Cancers
    Chaudary, N.
    Idris, A.
    McMillan, N.
    Hill, R. P.
    Milosevic, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S226 - S227
  • [5] Augmentation of standard chemotherapy response by inhibition of Aurora kinase A in preclinical models of pancreatic cancer
    Kronenberger, David
    Schwarz, Margaret A.
    Hassan, Md Sazzad
    von Holzen, Urs
    Schwarz, Roderich E.
    Awasthi, Niranjan
    CANCER RESEARCH, 2022, 82 (12)
  • [6] Synthesis and preclinical evaluation of radiolabeled alisertib as an investigational aurora kinase A PET tracer
    Verbeek, Joost
    Goos, Jeroen A. C. M.
    Geldof, Albert A.
    Hiemstra, Annemieke C.
    Hoekstra, Otto S.
    Meijer, Gerrit A.
    Stroud, Steven
    Bradley, Daniel
    Fijneman, Remond Ja
    Windhorst, Albert D.
    CANCER RESEARCH, 2014, 74 (19)
  • [7] Targeted inhibition of Aurora kinase A promotes immune checkpoint inhibition efficacy in human papillomavirus-driven cancers
    Ghosh, Soma
    O'Hara, Madison P.
    Sinha, Pragya
    Mazumdar, Tuhina
    Yapindi, Lacin
    Sastry, Jagannadha K.
    Johnson, Faye M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (01)
  • [8] Effects of dual inhibition of EGFR and Aurora A kinase in a lung cancer model
    Bagnyukova, Tetyana
    Pan, Xiaofan
    Zhang, Jiping
    Egleston, Brian
    Astsaturov, Igor
    Golemis, Erica
    Borghaei, Hossein
    CANCER RESEARCH, 2014, 74 (19)
  • [9] Rational combination of mTOR and Aurora kinase A inhibition in preclinical models of triple-negative breast cancer
    Diamond, Jennifer R.
    Orth, James D.
    Ionkina, Anastasia
    Dailey, Kyrie
    Pitts, Todd M.
    Capasso, Anna
    Marcus, Joshua M.
    Burke, Russell T.
    Davis, Sarah L.
    Kim, Jiyhe
    Tan, Aik-Choon
    Eckhardt, Sue G.
    Tentler, John J.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [10] Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus-Driven Cancers
    Ghosh, Soma
    Mazumdar, Tuhina
    Xu, Wei
    Powell, Reid T.
    Stephan, Clifford
    Shen, Li
    Shah, Pooja A.
    Pickering, Curtis R.
    Myers, Jeffery N.
    Wang, Jing
    Frederick, Mitchell J.
    Johnson, Faye M.
    CLINICAL CANCER RESEARCH, 2022, 28 (20) : 4479 - 4493